Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals.
about
Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissueTurning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)How to Define the Latent Reservoir: Tools of the TradeHIV-1 eradication strategies: design and assessmentEmerging strategies to deplete the HIV reservoirEpisomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failureStability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance GenotypingCpG methylation controls reactivation of HIV from latency.An array of novel murine spleen focus-forming viruses that activate the erythropoietin receptor.Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisCell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1.Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cellsComparative analysis of measures of viral reservoirs in HIV-1 eradication studiesParticle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloningChallenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patientHeterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistenceImpact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy.Eradicating HIV-1 infection: seeking to clear a persistent pathogen.Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activityProductive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies.HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni.Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1.Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.HIV reservoirs and latency models.Tissue reservoirs of HIVDefective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.The remarkable frequency of human immunodeficiency virus type 1 genetic recombinationSimple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01-AE, CRF07-BC, and CRF08-BC.Towards an HIV-1 cure: measuring the latent reservoir.Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report.HIV-1 Eradication: Early Trials (and Tribulations).Reduced Frequency of Cells Latently Infected with Replication-Competent HIV-1 in Virally Suppressed Individuals Living in Rakai, Uganda.Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Establishment and stability of the latent HIV-1 DNA reservoir.
P2860
Q24562082-C8DBE5D1-099E-4EF2-90B0-164ED3135EC9Q24645606-EEEB1650-AD53-4DA9-81BA-D0F423684D2EQ26766705-CE81FC70-7048-4794-8159-FDEF1F18AF20Q26864933-315965CE-5553-4305-AB1D-9314F397C2AEQ27023877-265990C0-877D-4A93-88E1-10C6C544F604Q28477257-B81FCA42-AF69-4829-9303-B96ED18EF8BEQ28546274-261FB4C4-A281-4943-9473-76247B3A7201Q33495565-3AB10327-3FDA-450C-843D-746CF57E20BAQ33782640-4298A51E-FCE3-495A-B9E1-E6AF30F045E0Q33902540-C13C0069-EABE-4F54-AB12-4859B9D45DFAQ33908859-E481DDB3-1387-4D68-97C1-9F042D624602Q34010283-F2350420-E221-4574-81F4-76DEEC7607AAQ34500786-ABFE89D7-2EAE-4DAB-BEBC-53A280521B35Q34594969-DC863A72-BAAC-4F62-B3F1-169FBAD6422EQ34607763-2448AEF0-183C-4C57-8199-CEEF5ABA8AAEQ34614272-C533E8AE-F856-46E7-8D46-340EA1E51B6FQ34720281-6F989519-F656-44A2-9909-B7A43D3E280EQ34871994-278C0DBC-87E2-4F8F-AAE0-AB6E90288D25Q34960856-9143D05A-79CB-496F-A00E-A5A4C7CF36EFQ35123201-6CA5D52B-7286-490A-965F-4070D1CFCDEFQ35252186-FB5609D5-B157-4619-8B9C-CD2BAB12E032Q35761152-30718146-DB07-46C7-8725-BD7DC20A4475Q36098975-077EF998-04BB-424C-AA4B-F1383182F36BQ36148964-806459AB-1643-4996-A2D6-179727826ADCQ36169656-C697D9AD-280B-4EF9-A27C-B4DD14C686AEQ36217786-D1486C00-41F7-4069-94E2-8890506A2D92Q36225040-D20C0C8D-CAA2-4EF7-8264-5D3E2F18E7DAQ36315149-D6CE8B62-B73D-4A49-9314-3D1FDD46CC05Q36528412-DC5E38FD-E59A-4654-ADC8-627EC2916C1FQ36746403-112F164C-8917-4CD0-B1CE-FD2D2EFC9D04Q37055454-B44A06E1-F8E4-45DE-BE97-6F09D3550038Q37161557-48283B10-3BCE-4C4B-AF83-73033A82ECA7Q37333701-712D4ECE-FCEA-4D65-B894-C2F561EA9100Q37511396-245F296C-DE51-42FC-A5AD-355AC964C4EEQ38369541-3445BC94-861B-4AD3-89CF-F66D40CCF5B7Q38426375-F3CCEFC9-7B50-4D26-8593-A141EA633E6AQ38675631-E508C4CC-BBC0-4C12-9C96-3738EED064DAQ38850174-7E9C0A75-A5B6-46C9-A917-73ACE0B548B2Q38936786-C790A24C-D135-4374-96A8-57AD56A2B37BQ39181055-E67A6AD9-731C-4255-8E29-8357195B3BB0
P2860
Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Accumulation of defective vira ...... s type 1-infected individuals.
@ast
Accumulation of defective vira ...... s type 1-infected individuals.
@en
type
label
Accumulation of defective vira ...... s type 1-infected individuals.
@ast
Accumulation of defective vira ...... s type 1-infected individuals.
@en
prefLabel
Accumulation of defective vira ...... s type 1-infected individuals.
@ast
Accumulation of defective vira ...... s type 1-infected individuals.
@en
P2093
P2860
P1433
P1476
Accumulation of defective vira ...... us type 1-infected individuals
@en
P2093
P2860
P304
P407
P50
P577
1997-03-01T00:00:00Z